Diagnosis of trichomoniasis: Comparison of wet mount with nucleic acid amplification assays
This supplement is sponsored by Hologic® | Gen-Probe
January 24, 2013|ObGyn
Author and Disclosure Information
Kimberle Chapin, MD
Dr. Chapin received research support for testing reagents and/or is a speaker for Hologic, Inc; Luminex Corporation; BD; GenMark Diagnostics Inc; Thermo Fischer Scientific Inc; and Meridian Bioscience, Inc.
Trichomonas vaginalis (TV) is the most prevalent treatable sexual transmitted infection (STI) in the United States, with a prevalence recently estimated at 8.7% in women aged 18 to 81 from a diverse geographic distribution.1,2
